PRTFDC1 Activators consist of various chemical compounds that indirectly upregulate the functional activity of PRTFDC1 through their influence on the purine salvage pathway and the availability of substrates and cofactors. Adenosine monophosphate (AMP) and dipyridamole, by increasing intracellular AMP levels, provide the necessary substrate for PRTFDC1's reaction, thus enhancing its enzymatic activity. Similarly, inosine contributes to the pool of substrates directly utilized by PRTFDC1. The presence of zinc sulfate and magnesium chloride provides essential cofactors that are crucial for the optimal catalytic function of PRTFDC1. In addition, compounds such as nicotinamide adenine dinucleotide (NAD+) and folic acid indirectly support the activity of PRTFDC1 by ensuring an adequate supply of purine nucleotides, which are necessary for its function. Glycine and glutamine serve as precursors in the de novo synthesis of purines, thereby indirectly increasing the availability of substrates for PRTFDC1's enzymatic action. Methotrexate, by inhibiting dihydrofolate reductase, leads to a compensatory increase in purine synthesis, which indirectly upregulates PRTFDC1 activity by boosting substrate levels.
The activity of PRTFDC1 is further influenced by chemicals that directly provide substrates or modulate their levels within the purine metabolic pathways. 5-Phosphoribosyl 1-pyrophosphate (PRPP) directly enhances PRTFDC1 by serving as a phosphate donor for the enzymatic reactions it catalyzes. Allopurinol, through its inhibition of xanthine oxidase, increases the concentration of hypoxanthine and xanthine, both of which are substrates in the purine salvage pathway, thereby enhancing PRTFDC1 activity by substrate availability. These activators collectively ensure that PRTFDC1 operates efficiently within the purine salvage pathway by either supplying essential substrates or cofactors, or by influencing the synthesis and metabolism of purines, leading to an increased functional throughput of the enzyme without necessitating changes in its expression levels.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Allopurinol | 315-30-0 | sc-207272 | 25 g | $128.00 | ||
Allopurinol is a xanthine oxidase inhibitor, which leads to increased levels of hypoxanthine and xanthine, substrates in the purine salvage pathway. The increased substrate availability can enhance the activity of PRTFDC1. | ||||||